Search

Author/Creator Fazekas, Andreas

1. Comparison of RECIST, iRECIST, and PERCIST for the Evaluation of Response to PD-1/PD-L1 Blockade Therapy in Patients With Non–Small Cell Lung Cancer. (July 2019)

Authors:
Beer, Lucian; Hochmair, Maximilian; Haug, Alexander R.; Schwabel, Bernhard; Kifjak, Daria; Wadsak, Wolfgang; Fuereder, Thorsten; Fabikan, Hannah; Fazekas, Andreas; Schwab, Sophia; Mayerhoefer, Marius E.; Herold, Christian; Prosch, Helmut
Journal:
Clinical nuclear medicine
Issue:
Volume 44:Number 7(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Treatment of ALK-rearranged non-small-cell lung cancer with brigatinib as second or later lines: real-world observations from a single institution. Issue 7 (August 2019)

Authors:
Hochmair, Maximilian; Weinlinger, Christoph; Schwab, Sophia; Naber, Jakob; Setinek, Ulrike; Krenbek, Dagmar; Urban, Matthias H.; Fabikan, Hannah; Watzka, Stefan; Koger, Renate; Fazekas, Andreas; Bitterlich, Erwin; Valipour, Arschang; Burghuber, Otto C.
Journal:
Anti-cancer drugs
Issue:
Volume 30:Issue 7(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search